ArticleMicrobiologyOpen2026
A Simple and Label-Free Gold Nanoparticle Assay and Duplex PCR for Rapid Detection of Klebsiella pneumoniae K2.
Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Rapid, accurate, and cost-effective diagnostic tools are crucial for the early detection of bacterial pathogens, particularly Klebsiella pneumoniae, a leading cause of multidrug-resistant infections. In this study, we developed two molecular detection approaches: a simplified, label-free colorimetric assay using unmodified gold nanoparticles (AuNPs) with direct DNA addition, and a duplex PCR assay targeting the K2A and orf10 genes, two key virulence and identification markers of K. pneumoniae. The unmodified AuNP assay, employing a 20 bp K2A gene probe, enabled visible color change detection within 60 min, without the need for complex instrumentation, achieving a sensitivity of 1.56 ng/μL. Duplex PCR successfully amplified fragments of 532 bp (K2A) and 309 bp (orf10), with high sensitivity levels of 1 pg/μL and 0.07 ng/μL, respectively. This integrated strategy offers both visual rapid screening and molecular confirmation in a single workflow, improving diagnostic reliability while maintaining low cost and simplicity. The use of unmodified AuNPs eliminates the need for chemical functionalization, significantly reducing assay preparation time and cost. Together, these features make the proposed method a promising platform for point-of-care molecular diagnostics and epidemiological monitoring of K. pneumoniae in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.